<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Arq Bras Cardiol</journal-id><journal-id journal-id-type="iso-abbrev">Arq. Bras. Cardiol</journal-id><journal-id journal-id-type="publisher-id">abc</journal-id><journal-title-group><journal-title>Arquivos Brasileiros de Cardiologia</journal-title></journal-title-group><issn pub-type="ppub">0066-782X</issn><issn pub-type="epub">1678-4170</issn><publisher><publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26959403</article-id><article-id pub-id-type="pmc">4845704</article-id><article-id pub-id-type="doi">10.5935/abc.20160031</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Aerobic Training after Myocardial Infarction: Remodeling Evaluated by
Cardiac Magnetic Resonance</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Izeli</surname><given-names>Nataly Lino</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>dos Santos</surname><given-names>Aur&#x000e9;lia Juliana</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Cresc&#x000ea;ncio</surname><given-names>J&#x000fa;lio C&#x000e9;sar</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Gon&#x000e7;alves</surname><given-names>Ana Clara Campagnolo Real</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Papa</surname><given-names>Val&#x000e9;ria</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Marques</surname><given-names>Fabiana</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Pazin-Filho</surname><given-names>Ant&#x000f4;nio</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Gallo-J&#x000fa;nior</surname><given-names>Louren&#x000e7;o</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Schmidt</surname><given-names>Andr&#x000e9;</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/></contrib></contrib-group><aff id="aff1"><label>1</label>Divis&#x000e3;o de Cardiologia do Hospital das
Cl&#x000ed;nicas da Faculdade de Medicina de Ribeir&#x000e3;o Preto - USP,
Ribeir&#x000e3;o Preto, SP - Brazil</aff><aff id="aff2"><label>2</label>Divis&#x000e3;o de Emerg&#x000ea;ncia da Faculdade de
Medicina de Ribeir&#x000e3;o Preto - USP, Ribeir&#x000e3;o Preto, SP - Brazil</aff><author-notes><corresp id="c1"><bold>Mailing Address: Andr&#x000e9; Schmidt</bold>, Divis&#x000e3;o
de Cardiologia do Hospital das Cl&#x000ed;nicas - Faculdade de Medicina de
Ribeir&#x000e3;o Preto &#x02013; Universidade de S&#x000e3;o Paulo. Av. Bandeirantes 3900,
Monte Alegre. Postal Code 14048-900 &#x02013; Ribeir&#x000e3;o Preto, SP &#x02013; Brazil.
E-mail: <email>aschmidt@fmrp.usp.br</email></corresp></author-notes><pub-date pub-type="epub-ppub"><month>4</month><year>2016</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><month>4</month><year>2016</year></pub-date><volume>106</volume><issue>4</issue><fpage>311</fpage><lpage>318</lpage><history><date date-type="received"><day>14</day><month>9</month><year>2015</year></date><date date-type="rev-recd"><day>18</day><month>11</month><year>2015</year></date><date date-type="accepted"><day>19</day><month>11</month><year>2015</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Background</title><p>Numerous studies show the benefits of exercise training after myocardial
infarction (MI). Nevertheless, the effects on function and remodeling are
still controversial. </p></sec><sec><title>Objectives</title><p>To evaluate, in patients after (MI), the effects of aerobic exercise of
moderate intensity on ventricular remodeling by cardiac magnetic resonance
imaging (CMR). </p></sec><sec><title>Methods</title><p>26 male patients, 52.9 &#x000b1; 7.9 years, after a first MI, were assigned to
groups: trained group (TG), 18; and control group (CG), 8. The TG performed
supervised aerobic exercise on treadmill twice a week, and unsupervised
sessions on 2 additional days per week, for at least 3 months. Laboratory
tests, anthropometric measurements, resting heart rate (HR), exercise test,
and CMR were conducted at baseline and follow-up.</p></sec><sec><title>Results</title><p>The TG showed a 10.8% reduction in fasting blood glucose (p = 0.01), and a
7.3-bpm reduction in resting HR in both sitting and supine positions (p &#x0003c;
0.0001). There was an increase in oxygen uptake only in the TG (35.4
&#x000b1; 8.1 to 49.1 &#x000b1; 9.6 mL/kg/min, p &#x0003c; 0.0001). There was a
statistically significant decrease in the TG left ventricular mass (LVmass)
(128.7 &#x000b1; 38.9 to 117.2 &#x000b1; 27.2 g, p = 0.0032). There were no
statistically significant changes in the values of left ventricular
end-diastolic volume (LVEDV) and ejection fraction in the groups. The
LVmass/EDV ratio demonstrated a statistically significant positive
remodeling in the TG (p = 0.015). </p></sec><sec><title>Conclusions</title><p>Aerobic exercise of moderate intensity improved physical capacity and other
cardiovascular variables. A positive remodeling was identified in the TG,
where a left ventricular diastolic dimension increase was associated with
LVmass reduction. </p></sec></abstract><kwd-group><kwd>Exercise</kwd><kwd>Rehabilitation</kwd><kwd>Myocardial Infarction</kwd><kwd>Magnetic Resonance Spectroscopy</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Left ventricular (LV) remodeling after myocardial infarction (MI) is a complex and
multifactorial process with prognostic and therapeutic implications.<sup><xref rid="r1" ref-type="bibr">1</xref></sup> Minimizing LV remodeling with
medications improved survival and quality of life.<sup><xref rid="r2" ref-type="bibr">2</xref>-<xref rid="r4" ref-type="bibr">4</xref></sup></p><p>Exercise training has been shown to improve exercise capacity and reduce mortality,
amplifying potential therapeutic interventions.<sup><xref rid="r5" ref-type="bibr">5</xref></sup> In addition, aerobic exercise reduces cardiovascular risk
factors, which makes it further appealing as an adjuvant treatment.<sup><xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r7" ref-type="bibr">7</xref></sup></p><p>The benefits of exercise training in increasing aerobic capacity, as well as other
hemodynamic changes, are well documented. Nevertheless, the effects of exercise on
myocardial function and LV remodeling after MI are still controversial. Some studies
have suggested that exercise after MI further deteriorates cardiac function due to
additional stress over the infarcted area, infarct expansion, aneurysm formation, or
ejection fraction (EF) reduction.<sup><xref rid="r8" ref-type="bibr">8</xref>-<xref rid="r10" ref-type="bibr">10</xref></sup> Numerous studies have failed to
confirm these findings and suggested that exercise does not alter ventricular
parameters even in different training intensities.<sup><xref rid="r11" ref-type="bibr">11</xref>-<xref rid="r14" ref-type="bibr">14</xref></sup> Other
studies have shown that after a recent acute MI with systolic dysfunction, exercise
can attenuate ventricular remodeling and even reverse this process.<sup><xref rid="r15" ref-type="bibr">15</xref>-<xref rid="r18" ref-type="bibr">18</xref></sup></p><p>Heterogeneity related to patient sampling, intensity of training, measurement
techniques, or even a combination of these factors could be potential explanations
for that divergence.<sup><xref rid="r19" ref-type="bibr">19</xref></sup></p><p>We sought to evaluate the effects of aerobic exercise of moderate intensity,
performed in patients after MI on cardiac function through cardiac magnetic
resonance (CMR), a well-recognized gold standard technique for the quantification of
ventricular volumes, EF and myocardial mass.<sup><xref rid="r20" ref-type="bibr">20</xref></sup></p></sec><sec sec-type="methods"><title>Methods</title><p>Male patients were selected according to strict inclusion criteria during an 18-month
period. All patients presented an acute MI with ST elevation. Patients enrolled
should be younger than 70 years, clinically stable, on sinus rhythm and not
previously included in any cardiac rehabilitation program. It must also be no later
than 6 months after their first MI. Exclusion criteria included unstable coronary
artery disease, uncontrolled hypertension, malignant ventricular arrhythmia and
ventricular failure during exercise, Chagas disease, untreated thyroid function
disorders, neurological or orthopedic inability to perform physical exercises on a
treadmill, and general debility. Since cardiac rehabilitation was offered to all
patients as part of our institution standard of care, patients with inclusion
criteria but not willing to engage in the program, who accepted to perform the exams
of the protocol, were included as controls.</p><p>The study was approved by the local ethical committee. Written informed consent was
obtained from all patients.</p><sec><title>Study Design</title><p>Initially, all patients were evaluated by a cardiologist to provide a clinical
history and undergo physical examination with anthropometric measurements. When
necessary, medications were optimized. Patients in both groups underwent
laboratory tests that included complete blood count, lipid profile, and fasting
glucose. A functional evaluation was performed at baseline and after at least 3
months of aerobic exercise training, including resting heart rate (HR), exercise
testing and CMR. The first two were always performed in the morning, and no
medication was withdrawn. The intervention period (IP) for the trained group
(TG) was defined as the time between the first exercise training session and the
final CMR and clinical and laboratorial evaluations. The IP for the control
group (CG) was the period between the two CMR exams.</p></sec><sec><title>Resting HR</title><p>The resting HR was obtained beat-by-beat, using a modified MC5 electrocardiogram
lead, in the morning, and on currently prescribed medications. The volunteers
remained at rest in the supine position for 15 minutes, and in the sitting
position for 8 minutes. Patients were instructed to maintain a relaxed posture
without moving arms and legs, talking or sleeping. To obtain the mean HR, the
first ten beats were discarded and arithmetic mean was performed with the other
values.</p></sec><sec><title>Exercise Testing</title><p>Patients performed a symptom-limited treadmill exercise test with
electrocardiographic monitoring of three leads (MC5, D2M, and V2M), using the
<italic>Micromed Ergo PC</italic> software (S&#x000e3;o Paulo, Brazil). They
were instructed not to consume stimulating food substances, and not to perform
strenuous activities before the test. They underwent the modified Balke
protocol, with increments in treadmill speed and inclination every minute,
selected according to the physical capacity expected for each patient. The
electrocardiogram was monitored continuously. Blood pressure, HR, and signs and
symptoms were obtained every minute during exercise, and throughout the recovery
period. The following variables were obtained at peak exercise: HR, blood
pressure, oxygen uptake, metabolic equivalent, treadmill load, and rating of
perceived exertion (Borg CR10 scale).<sup><xref rid="r21" ref-type="bibr">21</xref></sup> The peak oxygen uptake was obtained indirectly, using
the treadmill speed and inclination at peak exercise.</p></sec><sec><title>MRI</title><p>All imaging was performed using a 1.5T unit (Magneton Vision, Siemens,
Erl&#x000e4;ngen, Germany). After initial scout imaging, breath-hold steady-state
free precession cine MR images were acquired along the vertical long axis (2-
and 4-chamber view) and a short axis stack (contiguous 8-mm-thick slices)
covering the ventricle extension. The later sequence was used to assess the LV
mass (LVmass), LV dimensions and EF. All images were blindly analyzed by a
single operator (A.S.) using Image J.<sup><xref rid="r22" ref-type="bibr">22</xref></sup> LV end-systolic volume and LV end-diastolic volume
(LVEDV) were calculated using Simpson's rule. The LVmass was determined by the
sum of the myocardial area (LV epicardial contour minus LV endocardial contour)
times slice thickness, and multiplied by the specific myocardial gravity
(1.05g/mL). The LVEF was calculated as the difference between LVEDV and LV
end-systolic volume, divided by LVEDV and multiplied by 100. No gadolinium
infusion was used.</p></sec><sec><title>Exercise Training Protocol</title><p>The aerobic exercise training was prescribed based on the peak HR or HR in the
ischemic threshold obtained during exercise testing. Exercise intensity was
determined at 50-70% of HR reserve (Karvonen's equation). The TG patients
participated in a supervised 30-minute treadmill session, twice a week in the
morning period, for at least 3 months. Each session was preceded by a 5-minute
warm-up and followed by a 5-minute cooling-down period. During each supervised
session, intensity of exercise (treadmill speed and inclination), HR, blood
pressure, and rating of perceived exertion (Borg CR10 scale) were recorded.
Patients were instructed to undergo more two unsupervised sessions each week,
adjusting the speed of walking by counting the radial pulse or using a pulse HR
monitor. Data from outside walking were registered in a dairy, in which the
patient reported the resting HR, exercise time, and HR during walking and after
5 minutes of recovery. During training sessions, the TG patients received
information regarding lifestyle modification strategies, regular physical
activity, healthy diet, importance of weight control, and stress reduction. The
CG underwent the usual clinical follow-up and was subsequently contacted to
perform the final exams. The volunteers' medications were not modified during
the IP.</p></sec><sec><title>Statistical Analysis</title><p>Continuous variables were expressed as mean &#x000b1; standard deviation.
Categorical variables were presented as percentages. The distribution of the
data was analyzed with the Shapiro-Wilk test. Categorical data were compared
with the chi-square and Fisher exact tests. Continuous data were assessed by the
Wilcoxon nonparametric rank-sum test (intragroup analysis) and Mann-Whitney
nonparametric test (intergroup analysis), with a significance level of 5%.
Statistical analysis was performed using the SPSS for Windows software (version
10.0, SPSS Inc., Chicago Illinois, USA).</p></sec></sec><sec sec-type="results"><title>Results</title><p>A total of 26 male patients (52.9 &#x000b1; 7.9 years) were enrolled in the study
after fulfilling the inclusion criteria and presenting no exclusion criteria. Since
8 of them were not willing to participate in the rehabilitation program, but agreed
to undergo the tests needed, they constituted the CG. The other 18 patients were the
TG. Seventeen patients received fibrinolytics on MI admission (TG = 10 and CG = 7; p
= 0.29). The TG had a lower prevalence of smoking and sedentary lifestyle than the
CG. Baseline clinical data of the two groups are summarized in <xref ref-type="table" rid="t1">Table 1</xref>. The IP was 136.7 &#x000b1; 26.2 days
for the TG, and 150.5 &#x000b1; 44.5 days for the CG (p = 0.87). The TG performed a
mean of 27.5 &#x000b1; 5.6 supervised training sessions. None of the groups had
clinical complications during the IP.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Baseline characteristics of the trained and control groups (TG and CG,
respectively)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1"><bold>TG n = 16</bold></th><th align="center" rowspan="1" colspan="1"><bold>CG n = 8</bold></th><th align="center" rowspan="1" colspan="1"><bold>p value</bold></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">54.1 &#x000b1; 7.0</td><td align="center" rowspan="1" colspan="1">50.3 &#x000b1; 9.7</td><td align="center" rowspan="1" colspan="1">0.87</td></tr><tr><td align="left" rowspan="1" colspan="1">Time from MI (days)</td><td align="center" rowspan="1" colspan="1">145.0 &#x000b1; 104.7</td><td align="center" rowspan="1" colspan="1">117.5 &#x000b1; 91.1</td><td align="center" rowspan="1" colspan="1">0.99</td></tr><tr><td align="left" rowspan="1" colspan="1">Killip class, I/II/III (n)</td><td align="center" rowspan="1" colspan="1">10/8/0</td><td align="center" rowspan="1" colspan="1">4/3/1</td><td align="center" rowspan="1" colspan="1">0.31</td></tr><tr><td align="left" rowspan="1" colspan="1">Weight (kg)</td><td align="center" rowspan="1" colspan="1">80.0 &#x000b1; 14.8</td><td align="center" rowspan="1" colspan="1">90.5 &#x000b1; 12.4</td><td align="center" rowspan="1" colspan="1">0.08</td></tr><tr><td align="left" rowspan="1" colspan="1">Body mass index (kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">28.1 &#x000b1; 3.9</td><td align="center" rowspan="1" colspan="1">30.2 &#x000b1; 3.1</td><td align="center" rowspan="1" colspan="1">0.34</td></tr><tr><td align="left" rowspan="1" colspan="1">EF (%)</td><td align="center" rowspan="1" colspan="1">45.1 &#x000b1; 11.8</td><td align="center" rowspan="1" colspan="1">44.9 &#x000b1; 11.0</td><td align="center" rowspan="1" colspan="1">0.80</td></tr><tr><td align="left" rowspan="1" colspan="1">Culprit lesion artery (%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">0.60</td></tr><tr><td align="left" rowspan="1" colspan="1">Left anterior descending</td><td align="center" rowspan="1" colspan="1">66.6</td><td align="center" rowspan="1" colspan="1">50.0</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Left circumflex coronary</td><td align="center" rowspan="1" colspan="1">16.7</td><td align="center" rowspan="1" colspan="1">37.5</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Right coronary artery</td><td align="center" rowspan="1" colspan="1">16.7</td><td align="center" rowspan="1" colspan="1">12.5</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Revascularization procedures (n)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">0.44</td></tr><tr><td align="left" rowspan="1" colspan="1">PTCA</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">CABG surgery</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Cardiovascular risk factors (%)</bold></td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension</td><td align="center" rowspan="1" colspan="1">61.1</td><td align="center" rowspan="1" colspan="1">75.0</td><td align="center" rowspan="1" colspan="1">0.67</td></tr><tr><td align="left" rowspan="1" colspan="1">Dyslipidemia</td><td align="center" rowspan="1" colspan="1">66.7</td><td align="center" rowspan="1" colspan="1">37.5</td><td align="center" rowspan="1" colspan="1">0.22</td></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes mellitus</td><td align="center" rowspan="1" colspan="1">22.2</td><td align="center" rowspan="1" colspan="1">37.5</td><td align="center" rowspan="1" colspan="1">0.64</td></tr><tr><td align="left" rowspan="1" colspan="1">Family history</td><td align="center" rowspan="1" colspan="1">44.4</td><td align="center" rowspan="1" colspan="1">37.5</td><td align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">Current smokers</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">50.0</td><td align="center" rowspan="1" colspan="1">0.0047</td></tr><tr><td align="left" rowspan="1" colspan="1">Sedentary</td><td align="center" rowspan="1" colspan="1">50.0</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">0.0098</td></tr><tr><td align="left" rowspan="1" colspan="1">Overweight</td><td align="center" rowspan="1" colspan="1">72.2</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">0.10</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Medical therapy (%)</bold></td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Antithrombotic agent</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x003b2;-blocker</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">ACEI or ARB</td><td align="center" rowspan="1" colspan="1">88.8</td><td align="center" rowspan="1" colspan="1">87.5</td><td align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">Statin</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">Diuretics</td><td align="center" rowspan="1" colspan="1">22.2</td><td align="center" rowspan="1" colspan="1">25.0</td><td align="center" rowspan="1" colspan="1">1.00</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>MI: myocardial infarction; EF: ejection fraction; PTCA: percutaneous
transluminal coronary angioplasty; CABG: coronary artery bypass
grafting; ACEI: angiotensin-converting-enzyme inhibitors; ARB:
angiotensin-receptor blockers.</p></fn></table-wrap-foot></table-wrap><sec><title>Anthropometric measurements and laboratory tests</title><p>Baseline anthropometric measurements were similar between the two groups. At the
end of the IP, the TG showed a decrease of 1.28 kg in weight and of 0.47
kg/m<sup>2</sup> in body mass index (BMI), with no statistical difference (p
= 0.17 and p = 0.15, respectively). We observed a statistically significant
increase in weight (3.8kg) and BMI (1.27 kg/m<sup>2</sup>) in the CG (p = 0.04
for both).</p><p>There were no differences between the groups for baseline measures of total
cholesterol (p = 0.64), triglycerides (p = 0.19), high-density-lipoprotein
cholesterol (HDL-c) (p = 0.4530), low-density-lipoprotein cholesterol (LDL-c) (p
= 0.53) and fasting glucose (p = 0.52) (<xref ref-type="table" rid="t2">Table
2</xref>). The TG showed changes in lipids and glucose levels at the end of
the exercise training protocol. Fasting glucose decreased significantly (106.0
&#x000b1; 26.4 to 94.5 &#x000b1; 14.8 mg/dL, p = 0.01). The lipid profile showed
improvement without statistical significance. Total cholesterol was reduced by
6% (p = 0.08). There was a mean reduction of 16.9% in triglycerides (p = 0.14).
HDL-c increased 5.1% (p = 0.42), LDL-c decreased 6.1% (p = 0.32). In CG there
was a trend to increase in total cholesterol (p = 0.46), triglycerides (p =
0.11) and fasting glucose (p = 0.47).</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Lipid profile and fasting glucose values (mean &#x000b1; SD) in the
trained and control groups (TG and CG, respectively) at baseline and
follow-up</p></caption><table frame="hsides" rules="groups"><thead><tr style="border-bottom-style:solid;border-bottom-width:thin"><th rowspan="2" align="left" colspan="1"><bold>Laboratory tests</bold></th><th colspan="2" align="center" rowspan="1"><bold>TG</bold></th><th colspan="2" align="center" rowspan="1"><bold>CG</bold></th></tr><tr><th align="center" rowspan="1" colspan="1"><bold>Baseline</bold></th><th align="center" rowspan="1" colspan="1"><bold>Follow-up</bold></th><th align="center" rowspan="1" colspan="1"><bold>Baseline</bold></th><th align="center" rowspan="1" colspan="1"><bold>Follow-up</bold></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Total cholesterol (mg/dL)</td><td align="center" rowspan="1" colspan="1">157.4 &#x000b1; 43.8</td><td align="center" rowspan="1" colspan="1">147.9 &#x000b1; 47.9</td><td align="center" rowspan="1" colspan="1">170.1 &#x000b1; 44.8</td><td align="center" rowspan="1" colspan="1">178.1 &#x000b1; 44.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Triglycerides (mg/dL)</td><td align="center" rowspan="1" colspan="1">168.5 &#x000b1; 76.7</td><td align="center" rowspan="1" colspan="1">140.1 &#x000b1; 66.4</td><td align="center" rowspan="1" colspan="1">226.0 &#x000b1; 112.9</td><td align="center" rowspan="1" colspan="1">319.1 &#x000b1; 194.1</td></tr><tr><td align="left" rowspan="1" colspan="1">HDL-c (mg/dL)</td><td align="center" rowspan="1" colspan="1">37.4 &#x000b1; 7.1</td><td align="center" rowspan="1" colspan="1">39.3 &#x000b1; 10.0</td><td align="center" rowspan="1" colspan="1">39.8 &#x000b1; 4.1</td><td align="center" rowspan="1" colspan="1">40.4 &#x000b1; 5.7</td></tr><tr><td align="left" rowspan="1" colspan="1">LDL-c (mg/dL)</td><td align="center" rowspan="1" colspan="1">86.3 &#x000b1; 36.8</td><td align="center" rowspan="1" colspan="1">81.0 &#x000b1; 34.8</td><td align="center" rowspan="1" colspan="1">73.8 &#x000b1; 12.2</td><td align="center" rowspan="1" colspan="1">73.2 &#x000b1; 27.3</td></tr><tr><td align="left" rowspan="1" colspan="1">Fasting glucose (mg/dL)</td><td align="center" rowspan="1" colspan="1">106.0 &#x000b1; 26.4</td><td align="center" rowspan="1" colspan="1">94.5 &#x000b1; 14.8<xref ref-type="table-fn" rid="TFN2">*</xref></td><td align="center" rowspan="1" colspan="1">114.8 &#x000b1; 42.5</td><td align="center" rowspan="1" colspan="1">122.4 &#x000b1; 38.8</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><label>*</label><p>p = 0.011.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Resting HR</title><p>No statistically significant difference was found at baseline between groups in
resting HR. The resting HR in TG in the sitting position showed a decrease from
62.4 &#x000b1; 9.1 to 55.1 &#x000b1; 5.9 bpm (p &#x0003c; 0.0001). In the supine
position, HR decreased from 61.6 &#x000b1; 9.7 to 54.3 &#x000b1; 6.5 bpm (p &#x0003c;
0.0001). No changes were observed in the CG.</p></sec><sec><title>Exercise testing</title><p>Chest pain was the reason for interruption in 3 participants of the TG at
baseline, and 2 had it again in the second exercise test. No CG participant had
chest pain in the baseline exam, but it was the reason for interruption of one
participant in the second test. Data from the exercise tests are summarized in
<xref ref-type="table" rid="t3">Table 3</xref>. No differences were observed
within or between groups in maximal HR or systolic blood pressure at baseline
and follow-up. The TG demonstrated a 38.7% increase in maximal oxygen uptake (p
&#x0003c; 0.0001). At the end of the training protocol, a statistically significant
increase in the maximum treadmill load, expressed by values of speed and
inclination in the TG, was noted. No changes occurred in the CG.</p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Data from exercise tests (mean &#x000b1; SD) from the trained and control
groups (TG and CG, respectively) at baseline and follow-up</p></caption><table frame="hsides" rules="groups"><thead><tr style="border-bottom-style:solid;border-bottom-width:thin"><th rowspan="2" align="left" colspan="1"><bold>Exercise tests</bold></th><th colspan="2" align="center" rowspan="1"><bold>TG</bold></th><th colspan="2" align="center" rowspan="1"><bold>CG</bold></th></tr><tr><th align="center" rowspan="1" colspan="1"><bold>Baseline</bold></th><th align="center" rowspan="1" colspan="1"><bold>Follow-up</bold></th><th align="center" rowspan="1" colspan="1"><bold>Baseline</bold></th><th align="center" rowspan="1" colspan="1"><bold>Follow-up</bold></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Peak HR (bpm)</td><td align="center" rowspan="1" colspan="1">132.0 &#x000b1; 20.2</td><td align="center" rowspan="1" colspan="1">140.2 &#x000b1; 20.1</td><td align="center" rowspan="1" colspan="1">127.0 &#x000b1; 21.0</td><td align="center" rowspan="1" colspan="1">125.4 &#x000b1; 26.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Peak systolic blood pressure (mmHg)</td><td align="center" rowspan="1" colspan="1">178.3 &#x000b1; 24.6</td><td align="center" rowspan="1" colspan="1">181.1 &#x000b1; 22.1</td><td align="center" rowspan="1" colspan="1">183.8 &#x000b1; 16.0</td><td align="center" rowspan="1" colspan="1">193.8 &#x000b1; 23.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Peak HR-pressure product (bpm.mmHg)</td><td align="center" rowspan="1" colspan="1">23598.6 &#x000b1; 5093.5</td><td align="center" rowspan="1" colspan="1">25540.8 &#x000b1; 5640.0</td><td align="center" rowspan="1" colspan="1">23612.5 &#x000b1; 6353.0</td><td align="center" rowspan="1" colspan="1">24312.5 &#x000b1; 5997.9</td></tr><tr><td align="left" rowspan="1" colspan="1">Metabolic equivalent (MET)</td><td align="center" rowspan="1" colspan="1">10.1 &#x000b1; 2.3</td><td align="center" rowspan="1" colspan="1">14.0 &#x000b1; 2.8<xref ref-type="table-fn" rid="TFN4">*</xref></td><td align="center" rowspan="1" colspan="1">8.7 &#x000b1; 2.7</td><td align="center" rowspan="1" colspan="1">8.6 &#x000b1; 2.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Peak oxygen uptake (mL/kg/min)</td><td align="center" rowspan="1" colspan="1">35.4 &#x000b1; 8.1</td><td align="center" rowspan="1" colspan="1">49.1 &#x000b1; 9.6<xref ref-type="table-fn" rid="TFN4">*</xref></td><td align="center" rowspan="1" colspan="1">30.3 &#x000b1; 9.5</td><td align="center" rowspan="1" colspan="1">30.2 &#x000b1; 8.9</td></tr><tr><td align="left" rowspan="1" colspan="1">Speed (mph)</td><td align="center" rowspan="1" colspan="1">3.07 &#x000b1; 0.5</td><td align="center" rowspan="1" colspan="1">3.8 &#x000b1; 0.7<xref ref-type="table-fn" rid="TFN4">*</xref></td><td align="center" rowspan="1" colspan="1">2.9 &#x000b1; 0.3</td><td align="center" rowspan="1" colspan="1">2.9 &#x000b1; 0.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Ramp inclination (%)</td><td align="center" rowspan="1" colspan="1">15.9 &#x000b1; 3.6</td><td align="center" rowspan="1" colspan="1">19.1 &#x000b1; 3.0<xref ref-type="table-fn" rid="TFN5">#</xref></td><td align="center" rowspan="1" colspan="1">13.5 &#x000b1; 4.9</td><td align="center" rowspan="1" colspan="1">13.0 &#x000b1; 3.5</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><p>HR: heart rate.</p></fn><fn id="TFN4"><label>*</label><p>p &#x0003c; 0.0001; </p></fn><fn id="TFN5"><label>#</label><p>p = 0.0026.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>MRI</title><p><xref ref-type="table" rid="t4">Table 4</xref> shows the LVEDV, LVmass, EF
values, and LVmass/EDV ratio in both groups. Baseline LV parameters were similar
in the two groups, except for ventricular mass (p = 0.0225) and indexed LVmass
(p = 0.0429), which were higher in the CG. The LVEDV increased slightly in both
groups, without significant differences. The EF showed no significant
modification in the groups during the study.</p><table-wrap id="t4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Cardiac magnetic resonance (CMR) measurements (mean &#x000b1; SD) from the
trained and control groups (TG and CG, respectively) at baseline and
follow-up</p></caption><table frame="hsides" rules="groups"><thead><tr style="border-bottom-style:solid;border-bottom-width:thin"><th rowspan="2" align="left" colspan="1"><bold>CMR</bold></th><th colspan="2" align="center" rowspan="1"><bold>TG</bold></th><th colspan="2" align="center" rowspan="1"><bold>CG</bold></th></tr><tr><th align="center" rowspan="1" colspan="1"><bold>Baseline</bold></th><th align="center" rowspan="1" colspan="1"><bold>Follow-Up</bold></th><th align="center" rowspan="1" colspan="1"><bold>Baseline</bold></th><th align="center" rowspan="1" colspan="1"><bold>Follow-Up</bold></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">EDV (mL)</td><td align="center" rowspan="1" colspan="1">110.7 &#x000b1; 43.5</td><td align="center" rowspan="1" colspan="1">116.8 &#x000b1; 38.2</td><td align="center" rowspan="1" colspan="1">126.3 &#x000b1; 39.4</td><td align="center" rowspan="1" colspan="1">134.3 &#x000b1; 42.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Indexed EDV (mL/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">38.5 &#x000b1; 14.1</td><td align="center" rowspan="1" colspan="1">40.6 &#x000b1; 12.3</td><td align="center" rowspan="1" colspan="1">42.2 &#x000b1; 12.5</td><td align="center" rowspan="1" colspan="1">44.4 &#x000b1; 11.9</td></tr><tr><td align="left" rowspan="1" colspan="1">EF (%)</td><td align="center" rowspan="1" colspan="1">45.1 &#x000b1; 11.8</td><td align="center" rowspan="1" colspan="1">46.8 &#x000b1; 10.0</td><td align="center" rowspan="1" colspan="1">44.9 &#x000b1; 11.0</td><td align="center" rowspan="1" colspan="1">42.6 &#x000b1; 11.6</td></tr><tr><td align="left" rowspan="1" colspan="1">LVmass (g)</td><td align="center" rowspan="1" colspan="1">128.7 &#x000b1; 38.9</td><td align="center" rowspan="1" colspan="1">117.2 &#x000b1; 27.2<xref ref-type="table-fn" rid="TFN7">*</xref></td><td align="center" rowspan="1" colspan="1">159.6 &#x000b1; 29.3<xref ref-type="table-fn" rid="TFN8">#</xref></td><td align="center" rowspan="1" colspan="1">167.8 &#x000b1; 49.7</td></tr><tr><td align="left" rowspan="1" colspan="1">Indexed LVmass (g/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">44.9 &#x000b1; 12.5</td><td align="center" rowspan="1" colspan="1">40.9 &#x000b1; 8.6<xref ref-type="table-fn" rid="TFN7">*</xref></td><td align="center" rowspan="1" colspan="1">53.6 &#x000b1; 10.4<xref ref-type="table-fn" rid="TFN9">&#x003c6;</xref></td><td align="center" rowspan="1" colspan="1">55.9 &#x000b1; 14.0</td></tr><tr><td align="left" rowspan="1" colspan="1">LVmass/EDV ratio (g/mL)</td><td align="center" rowspan="1" colspan="1">1.29 &#x000b1; 0.36</td><td align="center" rowspan="1" colspan="1">1.36 &#x000b1; 0.48<xref ref-type="table-fn" rid="TFN10">&#x000a7;</xref></td><td align="center" rowspan="1" colspan="1">1.05 &#x000b1; 0.22</td><td align="center" rowspan="1" colspan="1">1.30 &#x000b1; 0.37</td></tr></tbody></table><table-wrap-foot><fn id="TFN6"><p>EDV: end-diastolic volume; EF: ejection fraction; LV: left
ventricular.</p></fn><fn id="TFN7"><label>*</label><p>p = 0.0032;</p></fn><fn id="TFN8"><label>#</label><p>p = 0.0225 between baseline values of the two groups;</p></fn><fn id="TFN9"><label>&#x003c6;</label><p>p = 0.0429 between baseline values of the two groups;</p></fn><fn id="TFN10"><label>&#x000a7;</label><p>p = 0.015.</p></fn></table-wrap-foot></table-wrap><p>The LV mass showed a statistically significant 8.9% reduction in the TG (128.7
&#x000b1; 38.9 g to 117.2 &#x000b1; 27.2 g; p = 0.0032). Indexed LVmass
(g/m<sup>2</sup>) showed a statistically significant reduction in the TG (p
= 0.0032). An opposite trend occurred in the CG, but without statistical
significance. Also, a similar LVmass/EDV ratio was present at baseline (TG =
1.29 &#x000b1; 0.36 g/mL, and CG = 1.36 &#x000b1; 0.48 g/mL; p = 0.63). At the end
of the protocol, we observed a statistically significant reduction in the
LVmass/EDV ratio in the TG (p = 0.015), with a value of 1.05 &#x000b1; 0.22 g/mL.
In the CG, the LVmass/EDV ratio had a final value of 1.30 &#x000b1; 0.37 g/mL (p
&#x0003e; 0.99).</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>The present study demonstrated that aerobic exercise training provided a positive LV
remodeling, as evaluated by CMR, and modification of cardiovascular risk factors in
a sample of male individuals after a first acute MI. The exercise training protocol
was tailored to patients' needs after optimized pharmacological treatment to allow a
widespread application, even to patients with residual ischemia, reproducing what
happens in the "real world", where patients present inherent difficulties to adhere
to a cardiac rehabilitation program.</p><sec><title>Aerobic capacity</title><p>There was a statistically significant increase of 38.7% in the peak oxygen uptake
in the TG. This increase was associated with an increase in the peak power
during exercise, as shown by the higher values of treadmill speed and
inclination reached after the training period. Several studies have documented
an increase in the peak oxygen uptake, from 10% to 46%, in post-MI patients
undergoing a cardiac rehabilitation program,<sup><xref rid="r12" ref-type="bibr">12</xref>,<xref rid="r14" ref-type="bibr">14</xref>,<xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r17" ref-type="bibr">17</xref>,<xref rid="r19" ref-type="bibr">19</xref>,<xref rid="r23" ref-type="bibr">23</xref>-<xref rid="r25" ref-type="bibr">25</xref></sup> depending on the training intensity. There was also a
statistically significant reduction in resting HR in the TG, an expression of
the positive adaptation of the sinus node. It is also important to emphasize
that the reduction in resting HR decreases the risk of cardiovascular
events.<sup><xref rid="r26" ref-type="bibr">26</xref></sup> Also, during
aerobic exercise, it enables the increase of HR reserve from rest to maximum
physical exercise.<sup><xref rid="r27" ref-type="bibr">27</xref>,<xref rid="r28" ref-type="bibr">28</xref></sup> No favorable changes were
found in the CG, reinforcing the favorable effects of the aerobic training
protocol despite the use of &#x000df;-blockers.</p></sec><sec><title>Left ventricular function, volume and mass</title><p>To control or inhibit cardiac remodeling is a treatment target for patients after
MI. Many studies have shown that drugs like angiotensin-converting enzyme
inhibitors, angiotensin receptor blockers, &#x003b2;-blockers and aldosterone
antagonists present anti-remodeling properties.<sup><xref rid="r29" ref-type="bibr">29</xref></sup> However, the achieved results are so far
unsatisfactory.</p><p>Research continues in pharmacological and non-pharmacological interventions that
can reverse and/or inhibit this process. A recent meta-analysis has demonstrated
that even the time after a MI influences the results obtained.<sup><xref rid="r30" ref-type="bibr">30</xref></sup></p><p>CMR has been extensively validated as a precise tool to measure volumes and
masses in normal and pathological scenarios.<sup><xref rid="r31" ref-type="bibr">31</xref></sup> It has also been demonstrated that small samples can be
used to accurately determine mass and volume modifications following an
intervention.<sup><xref rid="r32" ref-type="bibr">32</xref></sup> No
change in LVEF or LVEDV could be demonstrated in both groups after aerobic
exercise training, which could reflect optimized pharmacological treatment.</p><p>In addition, LVmass decreased in TG and slightly increased in CG. Since both
groups were similar regarding MI characteristics, it seems reasonable to raise
the hypothesis that this opposite pattern could be attributed to the aerobic
exercise intervention.</p><p>The same opposite pattern was demonstrated regarding LVmass/EDV, with better
proportionality in the TG than in the CG, which developed eccentric remodeling.
An evidence has demonstrated that LVmass/EDV ratio is close to 1 in children and
adolescents.<sup><xref rid="r33" ref-type="bibr">33</xref>,<xref rid="r34" ref-type="bibr">34</xref></sup> Our results suggest a trend
toward reestablishment of a normal LVmass/EDV ratio in the TG. Another published
study has identified different patterns of ventricular hypertrophy as indicators
of worse prognosis in patients after MI in a 2-year follow-up.<sup><xref rid="r35" ref-type="bibr">35</xref></sup></p><p>Our results do not confirm the negative effect of exercise on cardiac remodeling
as observed by others.<sup><xref rid="r8" ref-type="bibr">8</xref>-<xref rid="r10" ref-type="bibr">10</xref></sup> There is evidence in the
literature that the benefits of exercise on cardiac function and remodeling
after MI are due to distinct mechanisms: improved endothelial function, reduced
systemic vascular resistance, reduced preload, adjustment in autonomic system,
reduction in HR and blood pressure at rest and in submaximal loads, and
reduction in the LV wall stress.<sup><xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r17" ref-type="bibr">17</xref>,<xref rid="r18" ref-type="bibr">18</xref>,<xref rid="r23" ref-type="bibr">23</xref>,<xref rid="r36" ref-type="bibr">36</xref></sup></p><p>Direct comparisons may be difficult because echocardiographic measurements for
mass and function were done with 2D echocardiographic techniques, based on
formulas and assumptions of the LV geometric shape.<sup><xref rid="r37" ref-type="bibr">37</xref></sup> Fewer studies have used CMR for mass and
function quantitation. Dubach et al.<sup><xref rid="r19" ref-type="bibr">19</xref></sup> have studied 25 patients after MI with reduced LVEF
(32.3 &#x000b1; 6%). Twelve patients were randomized to perform high-intensity
physical activity in a rehabilitation center. Patients in both groups underwent
CMR evaluations initially and after 2 months. They observed a nonsignificant
increase in LV end-systolic volume and LVEDV (2.5% and 4.8%, respectively) in
TG, and no changes occurred in LVmass and EF in the groups. These same patients
were followed up for 1 year, one group with vigorous physical activity, with a
weekly energy expenditure of approximately 2,100 Kcal more than the CG. The
cardiac volumes, mass and function measurements showed no significant
difference, indicating that no deleterious effect of cardiac rehabilitation
could be detected.<sup><xref rid="r38" ref-type="bibr">38</xref></sup> Schmid et
al.<sup><xref rid="r39" ref-type="bibr">39</xref></sup> have evaluated
38 post-MI patients with an EF of 50.4 &#x000b1; 12.7%, assigned either to
combined endurance training and resistance training or to endurance training
alone for 12 weeks. By CMR at the end of the training period, EF, stroke volume,
LVEDV and end-systolic volume increased slightly in both groups. No deleterious
effect on remodeling was observed.<sup><xref rid="r39" ref-type="bibr">39</xref></sup></p><p>Finally, the medications were maintained during the IP in the present study,
eliminating the possibility that the results may have been influenced by changes
in medication doses.</p></sec><sec><title>Study limitations</title><p>Our study has several limitations. The volunteers were not randomly assigned. For
ethical reasons cardiac rehabilitation is offered to all MI patients in our
institution as a standard of care. The CG participants did not accept to enroll
in the rehabilitation program, but accepted to undergo the tests. This may be
more close to the "real world" and allowed the completion of the protocol by all
patients in the TG. On the other hand, we observed that the baseline LVmass was
significantly different between the study groups. One possible explanation may
be our selection method, but no other suitable way was available. Sample size is
always a concern when dealing with continuous variables such as volumes and
mass, but using CMR to quantify them seems to be appropriate because of its high
reproducibility and accuracy.<sup><xref rid="r28" ref-type="bibr">28</xref></sup> In addition, previous studies have indicated that, even in
small samples, modifications due to interventions in structural and functional
parameters can be detected.<sup><xref rid="r29" ref-type="bibr">29</xref></sup></p><p>No specific infarct location was selected in order to provide a variety of
conditions close to what is seen in clinical practice. Also, for logistical
reasons, we have not performed images to quantify the extent of the scar area
through the late enhancement on CMR. Such information could be useful in
attempting to explain individual behavior in both groups.</p><p>Only male patients were included in our sample. This may have reduced the sample
size, but may have assured that no gender related influence on the remodeling
process would be present.<sup><xref rid="r40" ref-type="bibr">40</xref></sup></p><p>The peak oxygen uptake was obtained indirectly through equations. Cardiopulmonary
exercise analysis should be more appropriate for obtaining this variable.
However, all TG patients showed an increase in treadmill speed and
inclination.</p><p>The study showed the benefits of aerobic exercise training on functional capacity
and cardiac function of patients after MI. However, the physiological mechanisms
responsible for these changes were not evaluated.</p></sec></sec><sec sec-type="conclusions"><title>Conclusions</title><p>The present study showed a positive remodeling in the TG, as indicated by the slight
increase in diastolic LV size associated with a reduction in LVmass. This was
obtained with a moderate-intensity aerobic training that was effective in improving
peak oxygen uptake and promoted benefic cardiovascular adaptations associated with a
reduction in cardiovascular risk factors.</p></sec></body><back><fn-group><fn fn-type="con"><p><bold>Author contributions</bold></p><p>Conception and design of the research: Izeli NL, Santos AJ, Gon&#x000e7;alves
ACCR, Gallo-J&#x000fa;nior L, Schmidt A; Acquisition of data: Izeli NL,
Santos AJ, Cresc&#x000ea;ncio JC, Gon&#x000e7;alves ACCR, Gallo-J&#x000fa;nior
L, Schmidt A; Analysis and interpretation of the data: Izeli NL,
Cresc&#x000ea;ncio JC, Gallo-J&#x000fa;nior L, Schmidt A; Statistical analysis
and Writing of the manuscript: Izeli NL, Schmidt A; Critical revision of the
manuscript for intellectual content: Papa V, Marques F, Pazin-Filho A,
Gallo-J&#x000fa;nior L, Schmidt A.</p></fn><fn fn-type="conflict"><p><bold>Potential Conflict of Interest</bold></p><p>No potential conflict of interest relevant to this article was reported.</p></fn><fn fn-type="supported-by"><p><bold>Sources of Funding</bold></p><p>There were no external funding sources for this study.</p></fn><fn fn-type="other"><p><bold>Study Association</bold></p><p>This article is part of the thesis of master submitted by Nataly Lino Izeli, from
Faculdade de Medicina de Ribeir&#x000e3;o Preto da Universidade de S&#x000e3;o
Paulo.</p></fn></fn-group><ref-list><title>References</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Opie</surname><given-names>LH</given-names></name><name><surname>Commerford</surname><given-names>PJ</given-names></name><name><surname>Gersh</surname><given-names>BJ</given-names></name><name><surname>Pfeffer</surname><given-names>MA</given-names></name></person-group><article-title>Controversies in ventricular remodelling</article-title><source>Lancet</source><year>2006</year><volume>367</volume><issue>9507</issue><fpage>356</fpage><lpage>367</lpage><pub-id pub-id-type="pmid">16443044</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfeffer</surname><given-names>MA</given-names></name><name><surname>Lamas</surname><given-names>GA</given-names></name><name><surname>Vaughan</surname><given-names>DE</given-names></name><name><surname>Parisi</surname><given-names>AF</given-names></name><name><surname>Braunwald</surname><given-names>E</given-names></name></person-group><article-title>Effect of captopril on progressive ventricular dilatation after
anterior myocardial infarction</article-title><source>N Engl J Med</source><year>1988</year><volume>319</volume><issue>2</issue><fpage>80</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">2967917</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfeffer</surname><given-names>MA</given-names></name><name><surname>Braunwald</surname><given-names>E</given-names></name><name><surname>Moye</surname><given-names>LA</given-names></name><name><surname>Basta</surname><given-names>L</given-names></name><name><surname>Brown</surname><given-names>EJ</given-names><suffix>Jr</suffix></name><name><surname>Cuddy</surname><given-names>TE</given-names></name><etal/></person-group><article-title>Effect of captopril on mortality and morbidity in patients with
left ventricular dysfunction after myocardial infarction. Results of the
survival and ventricular enlargement trial. The SAVE
Investigators</article-title><source>N Engl J Med</source><year>1992</year><volume>327</volume><issue>10</issue><fpage>669</fpage><lpage>677</lpage><pub-id pub-id-type="pmid">1386652</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellenger</surname><given-names>NG</given-names></name><name><surname>Rajappan</surname><given-names>K</given-names></name><name><surname>Rahman</surname><given-names>SL</given-names></name><name><surname>Lahiri</surname><given-names>A</given-names></name><name><surname>Raval</surname><given-names>U</given-names></name><name><surname>Webster</surname><given-names>J</given-names></name><etal/><collab>CHRISTMAS Study Steering Committee and Investigators</collab></person-group><article-title>Effects of carvedilol on left ventricular remodelling in chronic
stable heart failure: a cardiovascular magnetic resonance
study</article-title><source>Heart</source><year>2004</year><volume>90</volume><issue>7</issue><fpage>760</fpage><lpage>764</lpage><pub-id pub-id-type="pmid">15201244</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wenger</surname><given-names>NK</given-names></name></person-group><article-title>Current status of cardiac rehabilitation</article-title><source>J Am Coll Cardiol</source><year>2008</year><volume>51</volume><issue>17</issue><fpage>1619</fpage><lpage>1631</lpage><pub-id pub-id-type="pmid">18436113</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>AM</given-names></name><name><surname>Haykowsky</surname><given-names>M</given-names></name><name><surname>Kryworuchko</surname><given-names>J</given-names></name><name><surname>MacClure</surname><given-names>T</given-names></name><name><surname>Scott</surname><given-names>J</given-names></name><name><surname>DesMeules</surname><given-names>M</given-names></name><etal/></person-group><article-title>A meta-analysis of randomized control trials of home-based
secondary prevention programs for coronary artery disease</article-title><source>Eur J Cardiovasc Prev Rehabil</source><year>2010</year><volume>17</volume><issue>3</issue><fpage>261</fpage><lpage>270</lpage><pub-id pub-id-type="pmid">20560165</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gassner</surname><given-names>LA</given-names></name><name><surname>Dunn</surname><given-names>S</given-names></name><name><surname>Piller</surname><given-names>N</given-names></name></person-group><article-title>Aerobic exercise and the post myocardial infarction patient: a
review of the literature</article-title><source>Heart Lung</source><year>2003</year><volume>32</volume><issue>4</issue><fpage>258</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">12891166</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jugdutt</surname><given-names>BI</given-names></name><name><surname>Michorowski</surname><given-names>BL</given-names></name><name><surname>Kappagoda</surname><given-names>CT</given-names></name></person-group><article-title>Exercise training after anterior Q wave myocardial infarction:
importance of regional left ventricular function and
topography</article-title><source>J Am Coll Cardiol</source><year>1988</year><volume>12</volume><issue>2</issue><fpage>362</fpage><lpage>372</lpage><pub-id pub-id-type="pmid">3392328</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehsani</surname><given-names>AA</given-names></name><name><surname>Miller</surname><given-names>TR</given-names></name><name><surname>Miller</surname><given-names>TA</given-names></name><name><surname>Ballard</surname><given-names>EA</given-names></name><name><surname>Schechtman</surname><given-names>KB</given-names></name></person-group><article-title>Comparison of adaptations to a 12- month exercise program and
late outcome in patients with healed myocardial infarction and ejection
fraction &#x0003c; 45% and &#x0003e; 50%</article-title><source>Am J Cardiol</source><year>1997</year><volume>79</volume><issue>9</issue><fpage>1258</fpage><lpage>1260</lpage><pub-id pub-id-type="pmid">9164899</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kubo</surname><given-names>N</given-names></name><name><surname>Ohmura</surname><given-names>N</given-names></name><name><surname>Nakada</surname><given-names>I</given-names></name><name><surname>Yasu</surname><given-names>T</given-names></name><name><surname>Katsuki</surname><given-names>T</given-names></name><name><surname>Fujii</surname><given-names>M</given-names></name><etal/></person-group><article-title>Exercise at ventilatory threshold aggravates left ventricular
remodeling in patients with extensive anterior acute myocardial
infarction</article-title><source>Am Heart J</source><year>2004</year><volume>147</volume><issue>1</issue><fpage>113</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">14691428</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cobb</surname><given-names>FR</given-names></name><name><surname>Williams</surname><given-names>RS</given-names></name><name><surname>McEwan</surname><given-names>P</given-names></name><name><surname>Jones</surname><given-names>RH</given-names></name><name><surname>Coleman</surname><given-names>RE</given-names></name><name><surname>Wallace</surname><given-names>AG</given-names></name></person-group><article-title>Effects of exercise training on ventricular function in patients
with recent myocardial infarction</article-title><source>Circulation</source><year>1982</year><volume>66</volume><issue>1</issue><fpage>100</fpage><lpage>108</lpage><pub-id pub-id-type="pmid">7083497</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jette</surname><given-names>M</given-names></name><name><surname>Heller</surname><given-names>R</given-names></name><name><surname>Landry</surname><given-names>F</given-names></name><name><surname>Blumchen</surname><given-names>G</given-names></name></person-group><article-title>Randomized 4-week exercise program in patients with impaired left
ventricular function</article-title><source>Circulation</source><year>1991</year><volume>84</volume><issue>4</issue><fpage>1561</fpage><lpage>1567</lpage><pub-id pub-id-type="pmid">1914097</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adachi</surname><given-names>H</given-names></name><name><surname>Koike</surname><given-names>A</given-names></name><name><surname>Obayashi</surname><given-names>T</given-names></name><name><surname>Umezawai</surname><given-names>S</given-names></name><name><surname>Aonuma</surname><given-names>K</given-names></name><name><surname>lnada</surname><given-names>M</given-names></name><etal/></person-group><article-title>Does appropriate endurance exercise training improve cardiac
function in patients with prior myocardial infarction</article-title><source>Eur Heart J</source><year>1996</year><volume>17</volume><issue>10</issue><fpage>1511</fpage><lpage>1521</lpage><pub-id pub-id-type="pmid">8909908</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otsuka</surname><given-names>Y</given-names></name><name><surname>Takaki</surname><given-names>H</given-names></name><name><surname>Okano</surname><given-names>Y</given-names></name><name><surname>Satoh</surname><given-names>T</given-names></name><name><surname>Aihara</surname><given-names>N</given-names></name><name><surname>Matsumoto</surname><given-names>T</given-names></name><etal/></person-group><article-title>Exercise training without ventricular remodeling in patients with
moderate to severe left ventricular dysfunction early after acute myocardial
infarction</article-title><source>Int J Cardiol</source><year>2003</year><volume>87</volume><issue>2-3</issue><fpage>237</fpage><lpage>244</lpage><pub-id pub-id-type="pmid">12559545</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giannuzzi</surname><given-names>P</given-names></name><name><surname>Temporelli</surname><given-names>PL</given-names></name><name><surname>Corra</surname><given-names>U</given-names></name><name><surname>Gattone</surname><given-names>M</given-names></name><name><surname>Giordano</surname><given-names>A</given-names></name><name><surname>Tavazzi</surname><given-names>L</given-names></name></person-group><article-title>Attenuation of unfavorable remodeling by exercise training in
postinfarction patients with left ventricular dysfunction: results of the
Exercise in Left Ventricular Dysfunction (ELVD) trial</article-title><source>Circulation</source><year>1997</year><volume>96</volume><issue>6</issue><fpage>1790</fpage><lpage>1797</lpage><pub-id pub-id-type="pmid">9323063</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giannuzzi</surname><given-names>P</given-names></name><name><surname>Temporelli</surname><given-names>PL</given-names></name><name><surname>Corra</surname><given-names>U</given-names></name><name><surname>Tavazzi</surname><given-names>L</given-names></name><collab>ELVD-CHF Study Group</collab></person-group><article-title>Antiremodeling effect of long-term exercise training in patients
with stable chronic heart failure: results of the Exercise in Left
Ventricular Dysfunction and Chronic Heart Failure (ELVD-CHF)
Trial</article-title><source>Circulation</source><year>2003</year><volume>108</volume><issue>5</issue><fpage>554</fpage><lpage>559</lpage><pub-id pub-id-type="pmid">12860904</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giallauria</surname><given-names>F</given-names></name><name><surname>Cirillo</surname><given-names>P</given-names></name><name><surname>Lucci</surname><given-names>R</given-names></name><name><surname>Pacileo</surname><given-names>M</given-names></name><name><surname>De Lorenzo</surname><given-names>A</given-names></name><name><surname>D'Agostino</surname><given-names>M</given-names></name><etal/></person-group><article-title>Left ventricular remodelling in patients with moderate systolic
dysfunction after myocardial infarction: favourable effects of exercise
training and predictive role of N-terminal pro-brain natriuretic
peptide</article-title><source>Eur J Cardiovasc Prev Rehabil</source><year>2008</year><volume>15</volume><issue>1</issue><fpage>113</fpage><lpage>118</lpage><pub-id pub-id-type="pmid">18277196</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wisl&#x000f8;ff</surname><given-names>U</given-names></name><name><surname>St&#x000f8;ylen</surname><given-names>A</given-names></name><name><surname>Loennechen</surname><given-names>JP</given-names></name><name><surname>Bruvold</surname><given-names>M</given-names></name><name><surname>Rognmo</surname><given-names>&#x000d8;</given-names></name><name><surname>Haram</surname><given-names>PM</given-names></name><etal/></person-group><article-title>Superior cardiovascular effect of aerobic interval training
versus moderate continuous training in heart failure patients: a randomized
study</article-title><source>Circulation</source><year>2007</year><volume>115</volume><issue>24</issue><fpage>3086</fpage><lpage>3094</lpage><pub-id pub-id-type="pmid">17548726</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubach</surname><given-names>P</given-names></name><name><surname>Myers</surname><given-names>J</given-names></name><name><surname>Dziekan</surname><given-names>G</given-names></name><name><surname>Goebbels</surname><given-names>U</given-names></name><name><surname>Reinhart</surname><given-names>W</given-names></name><name><surname>Vogt</surname><given-names>P</given-names></name><etal/></person-group><article-title>Effect of exercise training on myocardial remodeling in patients
with reduced left ventricular function after myocardial infarction:
application of magnetic resonance imaging</article-title><source>Circulation</source><year>1997</year><volume>95</volume><issue>8</issue><fpage>2060</fpage><lpage>2067</lpage><pub-id pub-id-type="pmid">9133516</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hundley</surname><given-names>WG</given-names></name><name><surname>Bluemke</surname><given-names>DA</given-names></name><name><surname>Finn</surname><given-names>JP</given-names></name><name><surname>Flamm</surname><given-names>SD</given-names></name><name><surname>Fogel</surname><given-names>MA</given-names></name><name><surname>Friedrich</surname><given-names>MG</given-names></name><etal/><collab>American College of Cardiology Foundation Task Force on Expert
Consensus Documents</collab></person-group><article-title>ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on
cardiovascular magnetic resonance: a report of the American College of
Cardiology Foundation Task Force on Expert Consensus
Documents</article-title><source>J Am Coll Cardiol</source><year>2010</year><volume>55</volume><issue>23</issue><fpage>2614</fpage><lpage>2662</lpage><pub-id pub-id-type="pmid">20513610</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borg</surname><given-names>GA</given-names></name></person-group><article-title>Psychophysical bases of perceived exertion</article-title><source>Med Sci Sports Exerc</source><year>1982</year><volume>14</volume><issue>5</issue><fpage>377</fpage><lpage>381</lpage><pub-id pub-id-type="pmid">7154893</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abr&#x000e0;moff</surname><given-names>MD</given-names></name><name><surname>Magalh&#x000e3;es</surname><given-names>PJ</given-names></name><name><surname>Ram</surname><given-names>SJ</given-names></name></person-group><article-title>Image processing with image</article-title><source>J Biophotonics International</source><year>2004</year><volume>11</volume><issue>7</issue><fpage>36</fpage><lpage>42</lpage></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giallauria</surname><given-names>F</given-names></name><name><surname>De Lorenzo</surname><given-names>A</given-names></name><name><surname>Pilerci</surname><given-names>F</given-names></name><name><surname>Manakos</surname><given-names>A</given-names></name><name><surname>Lucci</surname><given-names>R</given-names></name><name><surname>Psaroudaki</surname><given-names>M</given-names></name><etal/></person-group><article-title>Reduction of N terminal-pro-brain (B-type) natriuretic peptide
levels with exercise-based cardiac rehabilitation in patients with left
ventricular dysfunction after myocardial infarction</article-title><source>Eur J Cardiovasc Prev Rehabil</source><year>2006</year><volume>13</volume><issue>4</issue><fpage>625</fpage><lpage>632</lpage><pub-id pub-id-type="pmid">16874155</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bjarnason-Wehrens</surname><given-names>B</given-names></name><name><surname>McGee</surname><given-names>H</given-names></name><name><surname>Zwisler</surname><given-names>AD</given-names></name><name><surname>Piepoli</surname><given-names>MF</given-names></name><name><surname>Benzer</surname><given-names>W</given-names></name><name><surname>Schmid</surname><given-names>JP</given-names></name><etal/><collab>Cardiac Rehabilitation Section European Association of
Cardiovascular Prevention and Rehabilitation</collab></person-group><article-title>Cardiac rehabilitation in Europe: results from the European
Cardiac Rehabilitation Inventory Survey</article-title><source>Eur J Cardiovasc Prev Rehabil</source><year>2010</year><volume>17</volume><issue>4</issue><fpage>410</fpage><lpage>418</lpage><pub-id pub-id-type="pmid">20300001</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giallauria</surname><given-names>F</given-names></name><name><surname>Acampa</surname><given-names>W</given-names></name><name><surname>Ricci</surname><given-names>F</given-names></name><name><surname>Vitelli</surname><given-names>A</given-names></name><name><surname>Maresca</surname><given-names>L</given-names></name><name><surname>Mancini</surname><given-names>M</given-names></name><etal/></person-group><article-title>Effects of exercise training started within 2 weeks after acute
myocardial infarction on myocardial perfusion and left ventricular function:
a gated SPECT imaging study</article-title><source>Eur J Prev Cardiol</source><year>2012</year><volume>19</volume><issue>6</issue><fpage>1410</fpage><lpage>1419</lpage><pub-id pub-id-type="pmid">21965517</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orso</surname><given-names>F</given-names></name><name><surname>Baldasseroni</surname><given-names>S</given-names></name><name><surname>Maggioni</surname><given-names>AP</given-names></name></person-group><article-title>Heart rate in coronary syndromes and heart
failure</article-title><source>Prog Cardiovasc Dis</source><year>2009</year><volume>52</volume><issue>1</issue><fpage>38</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">19615492</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perret-Guillaume</surname><given-names>C</given-names></name><name><surname>Joly</surname><given-names>L</given-names></name><name><surname>Benetos</surname><given-names>A</given-names></name></person-group><article-title>Heart rate as a risk factor for cardiovascular
disease</article-title><source>Prog Cardiovasc Dis</source><year>2009</year><volume>52</volume><issue>1</issue><fpage>6</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">19615487</pub-id></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivas-Estany</surname><given-names>E</given-names></name><name><surname>Sixto-Fern&#x000e1;ndez</surname><given-names>S</given-names></name><name><surname>Barrera-Sarduy</surname><given-names>J</given-names></name><name><surname>Hern&#x000e1;ndez-Garc&#x000ed;a</surname><given-names>S</given-names></name><name><surname>Gonz&#x000e1;lez-Guerra</surname><given-names>R</given-names></name><name><surname>Stusser-Beltranena</surname><given-names>R</given-names></name></person-group><article-title>Effects of long-term exercise training on left ventricular
function and remodeling in patients with anterior wall myocardial
infarction</article-title><source>Arch Cardiol M&#x000e9;x</source><year>2013</year><volume>83</volume><issue>3</issue><fpage>167</fpage><lpage>173</lpage><pub-id pub-id-type="pmid">23906745</pub-id></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohn</surname><given-names>JN</given-names></name><name><surname>Ferrari</surname><given-names>R</given-names></name><name><surname>Sharpe</surname><given-names>N</given-names></name></person-group><article-title>Cardiac remodeling - concepts and clinical implications: a
consensus paper from an international forum on cardiac remodeling. Behalf of
an International Forum on Cardiac Remodeling</article-title><source>J Am Coll Cardiol</source><year>2000</year><volume>35</volume><issue>3</issue><fpage>569</fpage><lpage>582</lpage><pub-id pub-id-type="pmid">10716457</pub-id></element-citation></ref><ref id="r30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>YM</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Wu</surname><given-names>HF</given-names></name><name><surname>Bian</surname><given-names>ZP</given-names></name><etal/></person-group><article-title>The effects of different initiation time of exercise training on
left ventricular remodeling and cardiopulmonary rehabilitation in patients
with left ventricular dysfunction after myocardial
infarction</article-title><source>Disabil Rehabil</source><year>2015</year><month>5</month><volume>7</volume><fpage>1</fpage><lpage>9</lpage><comment>[Epub ahead of print]</comment></element-citation></ref><ref id="r31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyne</surname><given-names>JC</given-names></name><name><surname>Pennell</surname><given-names>DJ</given-names></name></person-group><article-title>Cardiovascular magnetic resonance in the quantitative assessment
of left ventricular mass, volumes and contractile function</article-title><source>Coron Artery Dis</source><year>2005</year><volume>16</volume><issue>6</issue><fpage>337</fpage><lpage>343</lpage><pub-id pub-id-type="pmid">16118538</pub-id></element-citation></ref><ref id="r32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellenger</surname><given-names>NG</given-names></name><name><surname>Davies</surname><given-names>LC</given-names></name><name><surname>Francis</surname><given-names>JM</given-names></name><name><surname>Coats</surname><given-names>AJS</given-names></name><name><surname>Pennell</surname><given-names>DJ</given-names></name></person-group><article-title>Reduction in sample size for studies of remodeling in heart
failure by the use of cardiovascular magnetic resonance</article-title><source>J Cardiovasc Magn Reson</source><year>2000</year><volume>2</volume><issue>4</issue><fpage>271</fpage><lpage>278</lpage><pub-id pub-id-type="pmid">11545126</pub-id></element-citation></ref><ref id="r33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poutanen</surname><given-names>T</given-names></name><name><surname>Jokinen</surname><given-names>E</given-names></name></person-group><article-title>Left ventricular mass in 169 healthy children and young adults
assessed by three-dimensional echocardiography</article-title><source>Pediatr Cardiol</source><year>2007</year><volume>28</volume><issue>3</issue><fpage>201</fpage><lpage>207</lpage><pub-id pub-id-type="pmid">17486397</pub-id></element-citation></ref><ref id="r34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fratz</surname><given-names>S</given-names></name><name><surname>Chung</surname><given-names>T</given-names></name><name><surname>Greil</surname><given-names>GF</given-names></name><name><surname>Samyn</surname><given-names>MM</given-names></name><name><surname>Taylor</surname><given-names>AM</given-names></name><name><surname>Buechel</surname><given-names>ER</given-names></name><etal/></person-group><article-title>Guidelines and protocols for cardiovascular magnetic resonance in
children and adults with congenital heart disease: SCMR expert consensus
group on congenital heart disease</article-title><source>J Cardiovasc Magn Reson</source><year>2013</year><volume>15</volume><issue>1</issue><fpage>51</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">23763839</pub-id></element-citation></ref><ref id="r35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>A</given-names></name><name><surname>Meris</surname><given-names>A</given-names></name><name><surname>Skali</surname><given-names>H</given-names></name><name><surname>Ghali</surname><given-names>JK</given-names></name><name><surname>Arnold</surname><given-names>JM</given-names></name><name><surname>Bourgoun</surname><given-names>M</given-names></name><etal/></person-group><article-title>Prognostic implications of left ventricular mass and geometry
following myocardial infarction: the VALIANT (VALsartan In Acute myocardial
iNfarcTion) Echocardiographic Study</article-title><source>JACC Cardiovasc Imaging</source><year>2008</year><volume>1</volume><issue>5</issue><fpage>582</fpage><lpage>591</lpage><pub-id pub-id-type="pmid">19356485</pub-id></element-citation></ref><ref id="r36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>H</given-names></name><name><surname>Luo</surname><given-names>M</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Kang</surname><given-names>W</given-names></name></person-group><article-title>Effects of 6 months exercise training on ventricular remodelling
and autonomic tone in patients with acute myocardial infarction and
percutaneous coronary intervention</article-title><source>J Rehabil Med</source><year>2008</year><volume>40</volume><issue>9</issue><fpage>776</fpage><lpage>779</lpage><pub-id pub-id-type="pmid">18843433</pub-id></element-citation></ref><ref id="r37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myerson</surname><given-names>SG</given-names></name><name><surname>Montgomery</surname><given-names>HE</given-names></name><name><surname>World</surname><given-names>MJ</given-names></name><name><surname>Pennell</surname><given-names>DJ</given-names></name></person-group><article-title>Left ventricular mass: reliability of M-mode and 2-dimensional
echocardiographic formulas</article-title><source>Hypertension</source><year>2002</year><volume>40</volume><issue>5</issue><fpage>673</fpage><lpage>678</lpage><pub-id pub-id-type="pmid">12411461</pub-id></element-citation></ref><ref id="r38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myers</surname><given-names>J</given-names></name></person-group><article-title>Effects of exercise training on abnormal ventilatory responses to
exercise in patients with chronic heart failure</article-title><source>Congest Heart Fail</source><year>2000</year><volume>6</volume><issue>5</issue><fpage>243</fpage><lpage>249</lpage><pub-id pub-id-type="pmid">12189284</pub-id></element-citation></ref><ref id="r39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmid</surname><given-names>JP</given-names></name><name><surname>Anderegg</surname><given-names>M</given-names></name><name><surname>Romanens</surname><given-names>M</given-names></name><name><surname>Morger</surname><given-names>C</given-names></name><name><surname>Noveanu</surname><given-names>M</given-names></name><name><surname>Hellige</surname><given-names>G</given-names></name><etal/></person-group><article-title>Combined endurance/resistance training early on, after a first
myocardial infarction, does not induce negative left ventricular
remodelling</article-title><source>Eur J Cardiovasc Prev Rehabil</source><year>2008</year><volume>15</volume><issue>3</issue><fpage>341</fpage><lpage>346</lpage><pub-id pub-id-type="pmid">18525391</pub-id></element-citation></ref><ref id="r40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piro</surname><given-names>M</given-names></name><name><surname>Della Bona</surname><given-names>R</given-names></name><name><surname>Abbate</surname><given-names>A</given-names></name><name><surname>Biasucci</surname><given-names>LM</given-names></name><name><surname>Crea</surname><given-names>F</given-names></name></person-group><article-title>Sex-related differences in myocardial remodeling</article-title><source>J Am Coll Cardiol</source><year>2010</year><volume>55</volume><issue>11</issue><fpage>1057</fpage><lpage>1065</lpage><pub-id pub-id-type="pmid">20223363</pub-id></element-citation></ref></ref-list></back></article>